Imaginostics
Orlando
About Imaginostics
Imaginostics is creating the next generation of precision medicine diagnostic and prognostic tools to serve clinicians and drug developers to transform personalized healthcare, accelerate drug development, and fight aging. Our proprietary MRI physics-based technology delivers 10X better vascular images and quantitative measurements for vascular structure, function, and leakage. Our technology and software are compatible with existing MRI scanners, and as a bonus, is compatible with safe iron supplement for contrast (not toxic gadolinium). We provide biomarker solutions through CROs to pharma and participate in pre-clinical and clinical research in a variety of focus areas collaborating with world-renowned researchers at leading institutions. To learn more, please visit: http://www.imaginostics.com
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.4M
- Funding stage: Seed
- Last round: Seed (Jun 2024)
- Website: imaginostics.com
- Phone: 833-674-7226
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/imaginostics-93079 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.